United Kingdom · Medical devices startup

Creavo Medical Technologies Ltd

Creavo Medical Technologies Ltd is a UK-based medical technology company founded in 2014, focusing on acute medical diagnostics, particularly in cardiology.

Funding reportedLast round: Series B

Medical devicesCoventry, United Kingdom

About Creavo Medical Technologies Ltd

Creavo Medical Technologies Ltd is a UK-based medical technology company founded in 2014, focusing on acute medical diagnostics, particularly in cardiology.

The company operates from facilities in Leeds and Coventry and was established to commercialize research from the University of Leeds. Creavo's main product, Vitalscan, is a portable, battery-operated, non-invasive bedside scanning device. It provides a rapid three- to five-minute test to help clinicians rule out ischaemic heart disease and acute coronary syndromes at the point of admission or triage. Vitalscan measures and stores electromagnetic fluctuations from heart activity, aiming to enhance patient flow and reduce unnecessary admissions in emergency care. The company's technology platform includes a patented method for detecting magnetic physiological indicators, with potential applications in understanding arrhythmias and diagnostics for other organs. Creavo primarily serves healthcare providers, including emergency departments and cardiology teams, in the UK and globally.

What company datasets say Creavo Medical Technologies Ltd raised

Funding, as reported

Reported in all19.6Min the source's currency
Rounds3
Last roundSeries B
Last round size17.7M
Last round dateJun 2017
Investors listed3

The company, in detail

What they build

Known for

medical technology medical diagnostics

Built with from their website

Google Cloud HostingOutlook

Sector
Medical devices
Region
England
Revenue
2.5M a year, as listed
Full record
Every detail in the company directory

Medical devices in United Kingdom

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Creavo Medical Technologies Ltd in front of investors. Or tell us what we have wrong.